Harvard Bioscience
HBIO
HBIO
54 hedge funds and large institutions have $80.6M invested in Harvard Bioscience in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
54
Holding in Top 10
2
Calls
$1K
Puts
–
Top Buyers
| 1 | +$2.04M | |
| 2 | +$900K | |
| 3 | +$418K | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$321K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$298K |
Top Sellers
| 1 | -$856K | |
| 2 | -$436K | |
| 3 | -$375K | |
| 4 |
IAM
ICM Asset Management
Spokane,
Washington
|
-$349K |
| 5 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$335K |